JPMorgan Chase & Co’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $957 | Buy |
209
+43
| +26% | +$197 | ﹤0.01% | 5740 |
|
|
2025
Q1 | $810 | Sell |
166
-11,718
| -99% | -$57.2K | ﹤0.01% | 5779 |
|
|
2024
Q4 | $79.9K | Buy |
11,884
+11,717
| +7,016% | +$78.7K | ﹤0.01% | 4847 |
|
|
2024
Q3 | $1.29K | Sell |
167
-152
| -48% | -$1.17K | ﹤0.01% | 5625 |
|
|
2024
Q2 | $1.91K | Sell |
319
-2,727
| -90% | -$16.3K | ﹤0.01% | 5512 |
|
|
2024
Q1 | $27.5K | Sell |
3,046
-1,580
| -34% | -$14.2K | ﹤0.01% | 5154 |
|
|
2023
Q4 | $43.8K | Sell |
4,626
-91,236
| -95% | -$864K | ﹤0.01% | 5049 |
|
|
2023
Q3 | $1.14M | Sell |
95,862
-12,106
| -11% | -$144K | ﹤0.01% | 3328 |
|
|
2023
Q2 | $2.65M | Sell |
107,968
-761
| -0.7% | -$18.6K | ﹤0.01% | 2875 |
|
|
2023
Q1 | $3.4M | Buy |
108,729
+1,642
| +2% | +$51.4K | ﹤0.01% | 2699 |
|
|
2022
Q4 | $7.54M | Buy |
107,087
+1,312
| +1% | +$92.4K | ﹤0.01% | 2109 |
|
|
2022
Q3 | $9.11M | Sell |
105,775
-4,379
| -4% | -$377K | ﹤0.01% | 1920 |
|
|
2022
Q2 | $9.11M | Buy |
110,154
+103,775
| +1,627% | +$8.58M | ﹤0.01% | 1958 |
|
|
2022
Q1 | $1.06M | Buy |
6,379
+4,628
| +264% | +$769K | ﹤0.01% | 3571 |
|
|
2021
Q4 | $293K | Buy |
1,751
+89
| +5% | +$14.9K | ﹤0.01% | 4349 |
|
|
2021
Q3 | $144K | Sell |
1,662
-838
| -34% | -$72.6K | ﹤0.01% | 4554 |
|
|
2021
Q2 | $136K | Buy |
2,500
+1,322
| +112% | +$71.9K | ﹤0.01% | 4662 |
|
|
2021
Q1 | $70K | Sell |
1,178
-208
| -15% | -$12.4K | ﹤0.01% | 4730 |
|
|
2020
Q4 | $72K | Sell |
1,386
-1,250
| -47% | -$64.9K | ﹤0.01% | 4369 |
|
|
2020
Q3 | $124K | Buy |
2,636
+403
| +18% | +$19K | ﹤0.01% | 3956 |
|
|
2020
Q2 | $115K | Buy |
2,233
+1,232
| +123% | +$63.4K | ﹤0.01% | 3902 |
|
|
2020
Q1 | $44K | Sell |
1,001
-6,816
| -87% | -$300K | ﹤0.01% | 4176 |
|
|
2019
Q4 | $313K | Buy |
7,817
+2,492
| +47% | +$99.8K | ﹤0.01% | 3649 |
|
|
2019
Q3 | $175K | Buy |
5,325
+1,497
| +39% | +$49.2K | ﹤0.01% | 3801 |
|
|
2019
Q2 | $275K | Buy |
3,828
+3,522
| +1,151% | +$253K | ﹤0.01% | 3632 |
|
|
2019
Q1 | $54K | Buy |
306
+174
| +132% | +$30.7K | ﹤0.01% | 4206 |
|
|
2018
Q4 | $31K | Buy |
132
+13
| +11% | +$3.05K | ﹤0.01% | 4408 |
|
|
2018
Q3 | $26K | Buy |
+119
| New | +$26K | ﹤0.01% | 4527 |
|